639.3000 5.05 (0.80%)
NSE Dec 19, 2025 15:31 PM
Volume: 341.2K
 

ICICI Securities Limited
Krishna Institute of Medical Sciences’ (KIMS) Q1FY24 sequential revenue growth of 5.2% was mainly driven by ARPOB improvement of 3.7% while occupancy and OPD consultations were largely flat. As guided by the management, Telangana belt margin normalised to ~31% due to surge in overheads and seasonality while addition of gastro unit in Andhra Pradesh (AP) dented margins of that belt.
Krishna Institute of Medical Sciences Ltd. is trading below all available SMAs
More from Krishna Institute of Medical Sciences Ltd.
Recommended